• Events
  • Stop by Booth #1135 at ASGCT 2024 to Discuss the Future of Cell and Gene Therapy!

    Apr 29, 2024

    KACTUS Booth #1135

    Next week, KACTUS is thrilled to participate in the 27th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT) in Baltimore. This event, a significant gathering for the gene and cell therapy community, offers an ideal platform for showcasing our advanced gene editing enzymes and reagents. At KACTUS, our goal for the meeting is to engage with industry leaders and researchers, demonstrate our innovative GMP-grade gene editing enzymes and reagents, and foster collaborations that drive forward the potential of gene therapies. The ASGCT Annual Meeting serves as a pivotal forum for sharing research, advancing knowledge, and networking with experts across the field.

    Poster #833

    Transforming Tumor Research: Engineering MHCs as Versatile Reagents

    Featured Products

    MHC Monomers & Tetramers

    AAV Titration ELISA Kits

    AccuBase Cytosine Base Editor

    GMP-Grade CRISPR Cas9

    Universal Cas9 ELISA Kit

    GMP-Ready AsCas12a

    Cytokines

    Laminin 521

    GMP-Grade MaxNuclease All-Purpose Endonuclease

    Why attend the ASGCT Annual Meeting? 

    With field-leading keynotes, 200+ scientific sessions, over 7,000 researchers in attendance, and an expanded exhibit hall, ASGCT 2024 is the nexus for gene and cell therapy discovery and networking. Register now to unlock the full educational and partnership potential of this premier event! 

    Event Details: 

    What: American Society of Gene & Cell Therapy 27th Annual Meeting 2024

    When: May 7-11, 2024

    Where: Baltimore Convention Center, Maryland

    Booth: #1135

    About KACTUS

    KACTUS excels in crafting and producing an array of superior-grade, highly active recombinant proteins and enzymes, catering to diverse sectors like antibody drug discovery, immunotherapy, gene therapy, and mRNA therapeutics. Our expansive catalog, boasting over 3000 recombinant proteins, encompasses a wide spectrum of targets, species, tags, and labels, each thoughtfully chosen to address the specific, unmet needs of scientists engaged in drug development. The hallmark of our product selection process is a rigorous emphasis on exceptional quality and a steadfast commitment to ensuring reliable supply, thereby upholding the highest standards of excellence and client satisfaction.


    More from > Events